Martinez-Vargas, Marina
Saini, Arun
Pradhan, Subhashree
Gardea, Luis
Stoll, Barbara
Didelija, Inka C.
Vijayan, K. Vinod
Nguyen, Trung C.
Cruz, Miguel A.
Funding for this research was provided by:
NIGMS (GM112806)
NHLBI (HL154688)
Article History
Received: 7 June 2024
Accepted: 16 August 2024
First Online: 29 August 2024
Declarations
:
: All animal procedures were reviewed and approved by the Baylor College of Medicine Animal Care and Use Committee (study number: AN-6148 Arginine Metabolism in Sepsis; approved May 1, 2014, to August 24, 2022).
: Not applicable
: M.A. Cruz and T. Nguyen are members of the board of A2 Therapeutics, Inc.